Until programmed death do us tolerant

by David W. Scott
Published 2022-11-01

Genetic Engineering of T Cells for Immune Tolerance

by David W. Scott
Published 2020-03-01

Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance

by David W. Scott
Published 2021-09-01

The Value of Money: Funding Sources and Philanthropic Priorities in Twentieth-Century American Mission

by David W. Scott
Published 2018-04-01

From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance

by David W. Scott
Published 2017-11-01

Examining the Carnegie Classification Methodology for Research Universities

by Robert Kosar, David W. Scott
Published 2018-01-01

Robust Multiple Regression

by David W. Scott, Zhipeng Wang
Published 2021-01-01

Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies

by David W. Scott, Kathleen P. Pratt
Published 2020-01-01

Denoising Non-Stationary Signals via Dynamic Multivariate Complex Wavelet Thresholding

by Kim C. Raath, Katherine B. Ensor, Alena Crivello, David W. Scott
Published 2023-11-01

Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis

by Wassim Elyaman, Samia J. Khoury, David W. Scott, Anne S. De Groot
Published 2011-01-01

Tolerating Factor VIII: Recent Progress

by Sebastien Lacroix-Desmazes, Jan Voorberg, David Lillicrap, David W. Scott, Kathleen P. Pratt
Published 2020-01-01

Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells

by Alessandra De Paula Pohl, Shivaprasad H. Venkatesha, Ai-Hong Zhang, David W. Scott
Published 2020-04-01

Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis.

by Aiping Qin, David W Scott, Meaghan M Rabideau, Emily A Moore, Barbara J Mann
Published 2011-01-01

Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision

by Patrick R. Adair, Yong Chan Kim, Ai-Hong Zhang, Jeongheon Yoon, David W. Scott
Published 2017-09-01

The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.

by Denise K Reaves, Katerina D Fagan-Solis, Karen Dunphy, Shannon D Oliver, David W Scott, Jodie M Fleming
Published 2014-01-01

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor

by Maria T. Georgescu, Paul C. Moorehead, Paul C. Moorehead, Tongyao Liu, Jennifer Dumont, David W. Scott, Christine Hough, David Lillicrap
Published 2020-02-01

A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma

by Mark Bosch, Ariz Akhter, Bingshu E. Chen, Adnan Mansoor, David Lebrun, David Good, Michael Crump, Lois Shepherd, David W. Scott, Douglas A. Stewart
Published 2018-02-01

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

by Roopesh Kansara, Joseph M. Connors, Kerry J. Savage, Alina S. Gerrie, David W. Scott, Graham W. Slack, Randy D. Gascoyne, Laurie H. Sehn, Diego Villa
Published 2016-10-01

Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes

by Leslie P. Cousens, Yan Su, Elizabeth McClaine, Xin Li, Frances Terry, Robert Smith, Jinhee Lee, William Martin, David W. Scott, Anne S. De Groot
Published 2013-01-01

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60

by Dean A. Regier, Brandon Chan, Sarah Costa, David W. Scott, Christian Steidl, Joseph M. Connors, Aly Karsan, Marco A. Marra, Robert Kridel, Ian Cromwell, Samantha Pollard
Published 2022-02-01